Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-07-15

FDA Approved: ESCITALOPRAM OXALATE — Original Application (Ascent Pharmaceuticals, Inc)

View source ↗

Summary

FDA approved escitalopram oxalate as a generic product for Ascent Pharmaceuticals, Inc (ANDA 215177). It is intended to be used for the same indications as esci…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Escitalopram Oxalate (escitalopram oxalate)

Snippet

ORIG AP for ESCITALOPRAM OXALATE (ESCITALOPRAM)